jRCT2061220089Recruiting
Untitled Trial
An Open Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long Term use of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension
Insmed Godo KaishaJapan Registry Clinical Trial
VerifiedJapan Registry Clinical Trial
Study focus
- Disease/Condition
- Pulmonary Arterial Hypertension
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Insmed Godo Kaisha
- Location
- United States of America;Argentina;Australia;Mexico;Phillipines;Austria;Belgium;Brazil;Denmark;Germa
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Primary pulmonary hypertensionOther secondary pulmonary hypertensionPulmonary heart disease and diseases of pulmonary circulationStenosis of pulmonary arteryPulmonary heart disease, unspecified
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCT2061220089
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCT2061220089 through Pure Global AI's free database. This phase not specified trial is sponsored by Insmed Godo Kaisha and is currently Recruiting. The study focuses on Pulmonary Arterial Hypertension.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.